Human rhomboid family-1 suppresses oxygen-independent degradation of hypoxia-inducible factor-1a in breast cancer

Cancer Research

Volumn 74, Issue 10, 2014, Pages 2719-2730

  Zhou, Zhuan ^a   Liu, Fangfang ^b,c   Zhang, Zhi Song ^a   Shu, Feifei ^a   Zheng, Yangyang ^a   Fu, Li ^b,c   Li, Lu Yuan ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; HUMAN RHOMBOID FAMILY 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MEMBRANE PROTEIN; OXYGEN; RECEPTOR FOR ACTIVATED C KINASE 1; TAXANE DERIVATIVE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CELL HYPOXIA; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE SILENCING; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MCF-7 CELLS; MIDDLE AGED; NEOPLASM PROTEINS; OXYGEN; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 84901266379     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1027     Document Type: Article

References (28)

1. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev pathol 2013;9:47-71.
2. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-40.
3. Gorlach A, Camenisch G, Kvietikova I, Vogt L, Wenger RH, Gassmann M. Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochim Biophys Acta 2000; 1493:125-34.
4. Yee Koh M, Spivak-Kroizman TR, Powis G. HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 2008;33:526-34.
5. Liu YV, Semenza GL. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 2007;6:656-9.
6. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM. Hsp90 regulates a von Hippel Lindau-independent hypoxiainducible factor-1 alpha-degradative pathway. J Biol Chem2002;277: 29936-44.
7. Nakagawa T, Guichard A, Castro CP, Xiao Y, Rizen M, Zhang HZ, et al. Characterization of a human rhomboid homolog, p100hRho/RHBDF1, which interacts with TGF-Alpha family ligands. Dev Dyn 2005;233: 1315-31.
8. Freeman M. Rhomboid proteases and their biological functions. Annu Rev Genet 2008;42:191-210.
9. Lemberg MK, Freeman M. Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases. Genome Res 2007;17:1634-46.
10. Zettl M, Adrain C, Strisovsky K, Lastun V, Freeman M. Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling. Cell 2011;145:79-91.
11. Yan Z, Zou H, Tian F, Grandis JR, Mixson AJ, Lu PY, et al. Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth. Mol Cancer Ther 2008;7:1355-64.
12. Zou H, Thomas SM, Yan ZW, Grandis JR, Vogt A, Li LY. Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells. FASEB J 2009;23:425-32.
13. Kraus S, Gioeli D, Vomastek T, Gordon V, Weber MJ. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res 2006; 66:11047-54.
14. Tavassoli FA DP.WHOclassification of tumours. Pathology & genetics tumours of the breast and female genital organs. Lyon, France; IARC Press 2003:28-9.
15. Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003;12:320-7.
16. Koomagi R, Volm M. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer 1999;84:239-43.
17. Saponaro C, Malfettone A, Ranieri G, Danza K, Simone G, Paradiso A, et al. VEGF, HIF-1alpha expression and MVD as an angiogenic network in familial breast cancer. PloS ONE 2013;8: e53070.
18. Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, et al. Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol 2009;100:89-94.
19. Liu F, Cui L, Zhang Y, Chen L, Wang Y, Fan Y, et al. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Res Treat 2010;124:677-88.
20. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
21. Kaelin WG Jr. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008;8:865-73.
22. Liu YV, Hubbi ME, Pan F, McDonald KR, Mansharamani M, Cole RN, et al. Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization. J Biol Chem 2007;282:37064-73.
23. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-4.
24. Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, et al. HighHSP90 expression is associated with decreased survival in breast cancer. Cancer Res 2007;67:2932-7.
25. Cao XX, Xu JD, Liu XL, Xu JW, Wang WJ, Li QQ, et al. RACK1: A superior independent predictor for poor clinical outcome in breast cancer. Int J Cancer 2009;127:1172-9.
26. Hussein D, Estlin EJ, Dive C, Makin GW. Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells. Mol Cancer Ther 2006;5: 2241-50.
27. Dong Z, Venkatachalam MA, Wang J, Patel Y, Saikumar P, Semenza GL, et al. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J Biol Chem 2001;276: 18702-9.
28. Pils B, Schultz J. Inactive enzyme-homologues find new function in regulatory processes. J Mol Biol 2004;340:399-404.